SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
轻松的流沙
Lv3
220 积分
2023-09-01 加入
最近求助
最近应助
互助留言
OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 Study
13天前
已完结
Randomized phase II clinical trial comparing tremelimumab (CP-675,206) with best supportive care (BSC) following first-line platinum-based therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC)
14天前
已关闭
Lung cancer
7个月前
已关闭
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
7个月前
已完结
Harnessing big data to characterize immune-related adverse events
7个月前
已完结
Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment
8个月前
已完结
A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk
8个月前
已完结
Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis
9个月前
已完结
没有进行任何应助
文章欠缺,页面不全
7个月前
感谢,么么哒
7个月前
感谢
7个月前
感谢
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论